Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-07 9:37 pm Purchase | 2025-03-27 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 804,098 13.300% | 804,098 (New Position) | Filing History |
| 2025-04-03 6:00 pm Purchase | 2025-03-27 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 804,098 7.800% | 347 (+0.04%) | Filing History |
| 2025-02-14 5:41 pm Purchase | 2024-12-31 | 13G | Dermata Therapeutics, Inc. DRMA | ARMISTICE CAPITAL LLC | 276,422 9.990% | 90,211 (+48.45%) | Filing History |
| 2025-02-13 6:00 pm Unchanged | 2025-01-24 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 803,751 15.000% | 0 (Unchanged) | Filing History |
| 2025-01-28 5:25 pm Purchase | 2025-01-23 | 13G | Dermata Therapeutics, Inc. DRMA | Mitchell P. Kopin | 262,468 6.700% | 262,468 (New Position) | Filing History |
| 2025-01-23 9:54 pm Purchase | 2025-01-21 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 803,751 16.000% | 788,247 (+5084.05%) | Filing History |
| 2024-11-14 5:07 pm Purchase | 2024-09-30 | 13G | Dermata Therapeutics, Inc. DRMA | ARMISTICE CAPITAL LLC | 186,211 9.990% | 186,211 (New Position) | Filing History |
| 2024-02-14 3:35 pm Purchase | 2023-12-31 | 13G | Dermata Therapeutics, Inc. DRMA | ARMISTICE CAPITAL LLC | 27,474 9.990% | 27,474 (New Position) | Filing History |
| 2023-06-01 5:23 pm Purchase | 2023-05-23 | 13G | Dermata Therapeutics, Inc. DRMA | Mitchell P. Kopin | 9,596 4.990% | 9,596 (New Position) | Filing History |
| 2023-03-31 4:06 pm Purchase | 2023-03-20 | 13D | Dermata Therapeutics, Inc. DRMA | HALE DAVID F | 2,989 1.900% | 2,989 (New Position) | Filing History |
| 2023-03-30 4:06 pm Purchase | 2023-03-20 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 15,535 9.600% | 15,535 (New Position) | Filing History |
| 2023-01-18 5:01 pm Purchase | 2022-08-12 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 15,504 28.900% | 261 (+1.71%) | Filing History |
| 2022-05-05 5:00 pm Purchase | 2022-04-25 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 15,244 37.700% | 1,363 (+9.82%) | Filing History |
| 2021-08-27 5:02 pm Purchase | 2021-08-17 | 13D | Dermata Therapeutics, Inc. DRMA | HALE DAVID F | 2,597 7.500% | 2,597 (New Position) | Filing History |
| 2021-08-27 5:00 pm Purchase | 2021-08-17 | 13D | Dermata Therapeutics, Inc. DRMA | PROEHL GERALD T | 13,880 39.200% | 13,880 (New Position) | Filing History |